Alpha DNA Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Alpha DNA Investment Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-328	Closed	-$7K	–	752
2021 Q1	$7K	Hold	328	–	–	0.01%	326
2020 Q4	$4K	Buy	+328	New	+$4.35K	﹤0.01%	407

Alpha DNA Investment Management's GNMK Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 328 shares — an estimated $7K sold.

Alpha DNA Investment Management first reported a position in GNMK in Q4 2020 and held it in 2 quarters. The position peaked at $7K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Alpha DNA Investment Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 328 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $7K.
Alpha DNA Investment Management first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 2 quarters.
Alpha DNA Investment Management's GenMark Diagnostics, Inc position peaked at $7K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.